SUFFERING FROM HIGH BLOOD PRESSURE?

Be part of a clinical research study that is researching a study drug intended to reduce high blood pressure.

If you are between 30 and 85 years of age and are on medication but still have high blood pressure, you may be eligible.

NATRIX-SBP study

INTERESTED IN VOLUNTEERING IN THIS STUDY?

Be part of a clinical research study that is researching a study drug intended to reduce high blood pressure.

If you are between 30 and 85 years of age and are on medication but still have high blood pressure, you may be eligible.

NATRIX-SBP study

RING THE TRIAL HELPDESK TO FIND OUT MORE

Be part of a clinical research study that is researching a study drug intended to reduce high blood pressure.

If you are between 30 and 85 years of age and are on medication but still have high blood pressure, you may be eligible.

CALL 0161 515 3287

NATRIX-SBP study

Join the NATRIX-SBP study to help advance high blood pressure treatment research

Is your blood pressure still high despite being on medication? If so, you might be eligible to take part in an important clinical research study called NATRIX-SBP.
 
This study, sponsored by Regeneron Pharmaceuticals, Inc. and conducted by Protas (a UK-based not-for-profit clinical trials organisation), aims to determine whether the study drug can effectively lower blood pressure. The study drug is not approved for use outside of clinical studies.

Study overview

The aim of the NATRIX-SBP study is to see whether the study drug is effective in reducing blood pressure in people who have high blood pressure despite being on medication. Please note that this clinical trial will use an investigational drug product, the safety and efficacy of which has not been fully evaluated by regulatory authorities and which has not received marketing authorisation in any country.

Taking part in the NATRIX-SBP study is entirely voluntary. Around 732 people in the UK will take part in this study, which is divided into two parts, part A and part B. You will be in part A. If you decide to take part, you’ll be joining approximately 732 participants in a study that will last about 27 weeks, during which you’ll attend at least 10 face-to-face visits and at least one study phone call.

These visits are crucial for us to monitor your progress, administer the study drug (or placebo) and gather essential data.

Call us today to sign up

CALL 0161 515 3287

VIEW Study Summary

Why is this study important?

High blood pressure is a common condition, affecting an estimated 11.8 million adults in England alone. High blood pressure increases the risk of heart disease and strokes, which are among the leading causes of death in the UK.

Despite high blood pressure being extremely common, the World Health Organization estimates that only 1 in 5 adults with high blood pressure have it under control.

Some of the factors include patients being unable to tolerate their current medications or finding it difficult to take multiple tablets several times each day.

Why is this study important NATRIX-SBP study

Did you know?

  • High blood pressure is common

    Reveal

    High blood pressure is very common, about a third of adults in the UK have it, but many aren’t aware of it.

  • High blood pressure is linked to poor health

    Reveal

    If your blood pressure is too high, it puts extra strain on your heart and blood vessels. This is called high blood pressure, or hypertension. Over time it can lead to a number of health problems including heart attacks, stroke, kidney disease and some forms of dementia.

  • Lowering your blood pressure even a little is helpful

    Reveal

    The higher your blood pressure, the higher your risk of health problems, and lowering it is one of the best things you can do for your health. Even a small change can make a big difference – lowering the top number by 10mmHg lowers the risk of a heart attack or stroke by 20%.

Find out more

If you’re interested in learning more, please review the study summary sheet, which provides detailed information about the study.

To schedule your screening visit, contact our Trial Helpdesk. Your participation could help us discover a more effective way to manage high blood pressure for people everywhere.

Ring the Trial Helpdesk
0161 515 3287

Further resources: